TC
Schedule 13G filing
TANG CAPITAL MANAGEMENT LLC disclosed a 6% stake in Skye Bioscience, Inc. (SKYE)
TANG CAPITAL MANAGEMENT LLC reported owning 6% of Skye Bioscience, Inc. (SKYE) (263,560 shares) in a Schedule 13G filed Oct 14, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More SKYE insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.